after intermittent treatment with busulphan over a 7-year period for chronic myeloid leukemia ( cml ) in chronic phase , a 39-year-old female developed leukocytosis in association with pure red cell aplasia ( prca ) .
C0006463
busulphan
C0023473
chronic